LungLife AI, Inc.
LLAI.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | £6 | £15 | £8 | £26 |
| - Cash | £3 | £3 | £3 | £3 |
| + Debt | £0 | £0 | £0 | £1 |
| Enterprise Value | £3 | £13 | £6 | £24 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -73.9% | 0% | 64.3% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -£2 | -£3 | -£3 | -£3 |
| % Margin | -29,466.7% | -11,278.3% | -12,104.3% | -22,450% |
| Net Income | -£2 | -£3 | -£3 | -£3 |
| % Margin | -31,016.7% | -11,330.4% | -12,204.3% | -22,407.1% |
| EPS Diluted | -0.066 | -0.102 | -0.11 | -0.123 |
| % Growth | 35.8% | 7.3% | 10.6% | – |
| Operating Cash Flow | -£2 | -£2 | -£3 | -£3 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£2 | -£2 | -£3 | -£3 |